Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson(Oregon Health & Science University), Brad Glick(Mount Sinai Medical Center), Hany Elmaraghy(Eli Lilly (United States)), Ricardo Tan, Todd Schlesinger, Melinda Gooderham(Queen's University), Abel Jarell, Jennifer Soung(Probity Medical Research), Wendy McFalda, Jerry Bagel, Jamie Weisman(Institute for Advanced Medical Research), Scott Guenthner, Chitra R Natalie(Eli Lilly (United States)), Mirwais Saifi, Alison Ehrlich, Jose M Mendez, April W. Armstrong(University of California, Los Angeles), Jeffrey Crowley, Francis J Averill, Vivian Laquer(Johns Hopkins University), Paul W Wallace, Walter K. Nahm(Johns Hopkins University), Rosalyn Elizabeth George, Steve Sitar, Bruce Torkan, David Greenstein(Rockefeller University), Andreas Wollenberg(University Hospital Augsburg), Seth Forman, Howard Sofen(VA Sepulveda Ambulatory Care Center), Andrew Blauvelt(Veterans Health Administration), Melody Lynn Stone, Silvia Mariel Ferrucci(University of Milan), Evangeline Pierce(Eli Lilly (United States)), David F Fivenson, Angela Moore, Stephan Weidinger(University Hospital Schleswig-Holstein), Phoebe Rich, Sunil Dhawan, Neil S. Sadick(Cornell University), Renata Gontijo Lima(Eli Lilly (United States)), Wen Xu, Benjamin Lockshin(Georgetown University), Michael M. Witte(Eli Lilly (United States)), Eddie Armas, Jose M Carpio
JAMA Dermatology
January 11, 2023
Cited by 148


Related Papers